Matt Stammers
Overview
Explore the profile of Matt Stammers including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
76
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ardern-Jones M, Phan H, Borca F, Stammers M, Batchelor J, Reading I, et al.
PLoS One
. 2023 Jan;
18(1):e0280079.
PMID: 36649371
Background: The success of early dexamethasone therapy for hospitalised COVID-19 cases in treatment of Sars-CoV-2 infection may predominantly reflect its anti-inflammatory action against a hyperinflammation (HI) response. It is likely...
2.
Ardern-Jones M, Stammers M, Phan H, Borca F, Koutalopoulou A, Teo Y, et al.
Clin Med (Lond)
. 2021 Aug;
21(5):e543-e547.
PMID: 34389636
A significant proportion of COVID-19 patients show evidence of hyperinflammation (HI), of which secondary haemophagocytic lymphohistiocytosis (sHLH) is the most severe manifestation and diagnosed with HScore. Using a COVID-relevant modification...
3.
Carr E, Bendayan R, Bean D, Stammers M, Wang W, Zhang H, et al.
BMC Med
. 2021 Jan;
19(1):23.
PMID: 33472631
Background: The National Early Warning Score (NEWS2) is currently recommended in the UK for the risk stratification of COVID-19 patients, but little is known about its ability to detect severe...
4.
McDonnell M, Harris R, Borca F, Mills T, Downey L, Dharmasiri S, et al.
BMJ Open Gastroenterol
. 2020 Nov;
7(1).
PMID: 33187976
Background: Glucocorticosteroids (GC) are long-established, widely used agents for induction of remission in inflammatory bowel disease (IBD). Hyperglycaemia is a known complication of GC treatment with implications for morbidity and...